Comparison of the acute pulmonary vasodilating effect of beraprost sodium and nitric oxide in congenital heart disease - Thailand multicenter study
Background: Congenital heart disease patients who have pulmonary hypertension (PH) require an evaluation for pulmonary vascular reactivity before surgical repair. In the present study the acute pulmonary vasodilating effects of 100% oxygen (O2), beraprost sodium (BPS) and 40 ppm inhaled nitric oxide...
Saved in:
Main Authors: | Kritvikrom Durongpisitkul, Duangmanee Laoprasitiporn, Thanarat Layangool, Rekwan Sittiwankul, Mannat Panamonta, Pirapat Mokrapong |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=12344324471&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/62447 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Comparison of the acute pulmonary vasodilating effect of beraprost sodium and nitric oxide in congenital heart disease - Thailand multicenter study
by: Kritvikrom Durongpisitkul, et al.
Published: (2018) -
Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease
by: A. Limsuwan, et al.
Published: (2018) -
Beraprost as initial pharmacologic treatment for pulmonary hypertension related to left to right shunt congenital heart disease
by: Shirley Ferlina Lasmono, -, et al.
Published: (2021) -
Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease
by: Kritvikrom Durongpisitkul, et al.
Published: (2018) -
A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease
by: Kritvikrom Durongpisitkul, et al.
Published: (2018)